‘You Don’t Put Your Head in the Sand for 4 Years’: Colossal CEO Ben Lamm on Working With Trump
The company’s cofounder recently convinced the Trump administration to support an initiative to gather DNA samples from endangered species.
The DEA banned a drug some opioid users called a miracle
Researchers say the Schedule I ban could kill studies of a promising opioid treatment.
Watch: What is the zeptoverse?
BBC science correspondent, Pallab Ghosh, takes us into the zeptoverse and explains how it could change our ideas of how the universe works.
Billions of times smaller than an atom: What is the zeptoverse?
BBC science correspondent, Pallab Ghosh, takes us into the zeptoverse and explains how it could change our ideas of how the universe works.
Watch: Just how small is the zeptoverse?
BBC science correspondent, Pallab Ghosh, takes us into the zeptoverse and explains how it could change our ideas of how the universe works.
Why large dogs age faster than small ones, and other October research highlights
Plus invisible tattoos, medieval skeleton gets an ID, trapping a single antimatter particle, and more.
Most of our measures of a key cognitive process don’t agree
A big study with very little beyond negative results still gets published.
The world has a new plan to save nature, but it still needs the money
A new action plan aims to rescue 2030 nature targets as financing remains inadequate.
Seabirds racing home over the ocean can get jet-lagged
A long flight home from feeding grounds messes with birds' internal clocks.
The FDA wants to pull its approval of a drug. It’s not so easy.
The regulator says Tavneos was approved on the basis of manipulated study data. Should patients still have access to it?